Andrew R. Garbarino bought ORMP

April 23, 2021 · STOCK Act disclosure

Representative Andrew R. Garbarino (Republican-NY) bought Oramed Pharmaceuticals Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on April 23, 2021 and was disclosed on May 24, 2021 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.